The new Viral Respiratory Infection Array (VRI) will be conducted on Vivalytic, a point of care platform brought to the market by Randox Laboratories and Bosch. The Vivalytic system is a fully-automated, cartridge-based platform capable of both Hi-Plex and Lo-Plex testing. The VRI test can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses.
Vivalytic cartridges are compact, technologically advanced Molecular Diagnostic tests utilising micro-fluidics to enable simple and accurate diagnostic testing. Randox patented Biochip Array Technology powers Vivalytic, enabling end-point qualitative PCR and providing multiple test results from each sample.
Viral Respiratory Infection Array (10-plex)
VIRUSES - -
SARS-CoV-2 (COVID-19) - Sarbecovirus
(SARS, SARS like, SARS-CoV-2) - Influenza A
Coronavirus 229E/NL63 - Adenovirus A/B/C/D/E - Influenza B
Coronavirus OC43/HKUI - Enterovirus A/B/C - Rhinovirus A/B
Middle East Respiratory
Syndrome Coronavirus (MERS-CoV) - -
Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.
To begin the test, the user scans or enters sample information. The cartridge code is then scanned into the embedded Vivalytic software. The user then adds sample into the dedicated cartridge slot, closes the lid and inserts the cartridge into the Vivalytic.